Florian Oyen

3.3k total citations
52 papers, 1.4k citations indexed

About

Florian Oyen is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Florian Oyen has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 19 papers in Molecular Biology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Florian Oyen's work include Platelet Disorders and Treatments (25 papers), Chromatin Remodeling and Cancer (18 papers) and Cancer Mechanisms and Therapy (15 papers). Florian Oyen is often cited by papers focused on Platelet Disorders and Treatments (25 papers), Chromatin Remodeling and Cancer (18 papers) and Cancer Mechanisms and Therapy (15 papers). Florian Oyen collaborates with scholars based in Germany, United States and Netherlands. Florian Oyen's co-authors include Reinhard Schneppenheim, Tobias Obser, Michael C. Frühwald, Martin Hasselblatt, Reiner Siebert, Ulrich Budde, Stefan Gesk, Uwe Kordes, Astrid Jeibmann and Werner Paulus and has published in prestigious journals such as Blood, The American Journal of Human Genetics and American Journal Of Pathology.

In The Last Decade

Florian Oyen

50 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Oyen Germany 20 708 484 472 343 263 52 1.4k
Nathalie Gachard France 18 311 0.4× 565 1.2× 401 0.8× 397 1.2× 354 1.3× 57 1.3k
Lourdes Florensa Spain 23 596 0.8× 571 1.2× 1.0k 2.2× 212 0.6× 1.1k 4.3× 120 2.0k
Marie‐Christine Kyrtsonis Greece 18 376 0.5× 421 0.9× 471 1.0× 177 0.5× 497 1.9× 81 1.1k
Odilia B. J. Corneth Netherlands 22 244 0.3× 281 0.6× 155 0.3× 797 2.3× 374 1.4× 46 1.5k
María Luz Sánchez Spain 17 188 0.3× 338 0.7× 276 0.6× 538 1.6× 430 1.6× 22 1.1k
Pascale De Paepe Belgium 15 268 0.4× 564 1.2× 140 0.3× 233 0.7× 285 1.1× 36 999
S O'Brien United States 17 266 0.4× 934 1.9× 1.1k 2.2× 746 2.2× 1.2k 4.5× 36 2.3k
Manfred Hensel Germany 21 188 0.3× 903 1.9× 310 0.7× 517 1.5× 988 3.8× 68 1.6k
Paula G. Heller Argentina 23 287 0.4× 61 0.1× 819 1.7× 183 0.5× 528 2.0× 53 1.2k
Kenichi Chiba Japan 15 629 0.9× 155 0.3× 312 0.7× 118 0.3× 147 0.6× 49 1.1k

Countries citing papers authored by Florian Oyen

Since Specialization
Citations

This map shows the geographic impact of Florian Oyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Oyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Oyen more than expected).

Fields of papers citing papers by Florian Oyen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Oyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Oyen. The network helps show where Florian Oyen may publish in the future.

Co-authorship network of co-authors of Florian Oyen

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Oyen. A scholar is included among the top collaborators of Florian Oyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Oyen. Florian Oyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nemes, Karolina, Susanne Bens, Helene Kretzmer, et al.. (2024). Constitutional mosaicism of pathogenic variants in SMARCB1 in a subset of patients with sporadic rhabdoid tumors. Neuro-Oncology. 27(2). 533–544. 1 indexed citations
2.
Holsten, Till, Susanne Bens, Florian Oyen, et al.. (2018). Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis. European Journal of Human Genetics. 26(8). 1083–1093. 26 indexed citations
3.
Obser, Tobias, Florian Oyen, Maria A. Brehm, et al.. (2016). Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami. Journal of Thrombosis and Haemostasis. 14(9). 1725–1735. 7 indexed citations
4.
Grosse, Regine, Zoltán Lukács, Florian Oyen, et al.. (2015). The Prevalence of Sickle Cell Disease and Its Implication for Newborn Screening in Germany (Hamburg Metropolitan Area). Pediatric Blood & Cancer. 63(1). 168–170. 20 indexed citations
5.
Bartelheim, K., David Sumerauer, Uta Behrends, et al.. (2014). Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB). Cancer Genetics. 207(9). 379–383. 7 indexed citations
6.
Frühwald, Michael C., Martin Hasselblatt, Kornelius Kerl, et al.. (2014). Identifying molecular markers for the sensitive detection of residual atypical teratoid rhabdoid tumor cells. Cancer Genetics. 207(9). 390–397. 8 indexed citations
7.
Huck, Volker, Camilo Aponte‐Santamaría, Sandra Grässle, et al.. (2014). von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor. Thrombosis and Haemostasis. 112(7). 96–108. 30 indexed citations
8.
Budde, Ulrich, Florian Oyen, Meganathan Kannan, et al.. (2013). Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients. Thrombosis and Haemostasis. 109(4). 652–660. 20 indexed citations
9.
Lehmberg, Kai, Regine Grosse, Martina U. Muckenthaler, et al.. (2012). Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patients. Annals of Hematology. 92(3). 387–394. 16 indexed citations
10.
Boda, Z, Hajna Losonczy, Tamás Masszi, et al.. (2011). Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population. Journal of Thrombosis and Haemostasis. 9(5). 945–952. 11 indexed citations
11.
Hasselblatt, Martin, Stefan Gesk, Florian Oyen, et al.. (2011). Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression. The American Journal of Surgical Pathology. 35(6). 933–935. 166 indexed citations
12.
Schneppenheim, Reinhard, Michael C. Frühwald, Stefan Gesk, et al.. (2010). Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome. The American Journal of Human Genetics. 86(2). 279–284. 222 indexed citations
13.
Bug, Stefanie, Jan Dürig, Florian Oyen, et al.. (2009). Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A–TCRAD juxtaposition. Cancer Genetics and Cytogenetics. 192(1). 44–47. 14 indexed citations
14.
Kordes, Uwe, Stefan Gesk, Michael C. Frühwald, et al.. (2009). Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor. Genes Chromosomes and Cancer. 49(2). 176–181. 68 indexed citations
15.
Schneppenheim, Reinhard, Florian Oyen, Enke Grabhorn, et al.. (2008). Analysis of the CC chemokine receptor 5Δ32 polymorphism in pediatric liver transplant recipients. Pediatric Transplantation. 12(7). 769–772. 5 indexed citations
16.
Gupta, Pawan, Renu Saxena, Ulrich Budde, et al.. (2008). Genetic defects in von Willebrand disease type 3 in Indian and Greek patients. Blood Cells Molecules and Diseases. 41(2). 219–222. 20 indexed citations
17.
Schneppenheim, Reinhard, Giancarlo Castaman, Augusto B. Federici, et al.. (2007). A common 253‐kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3. Journal of Thrombosis and Haemostasis. 5(4). 722–728. 28 indexed citations
18.
Gerth, Jens, Martin Busch, Florian Oyen, et al.. (2007). Thrombotic microangiopathy in a 17-year-old patient: TTP, HUS or a bit of both?. Clinical Nephrology. 68(12). 405–411. 2 indexed citations
19.
Hovinga, Johanna A. Kremer, Tim Becker, Ulrich Budde, et al.. (2006). A common origin of the 4143insA ADAMTS13 mutation. Thrombosis and Haemostasis. 96(7). 3–6. 56 indexed citations
20.
Lenk, H., Tobias Obser, Johannes Oldenburg, et al.. (2004). Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization. Thrombosis and Haemostasis. 92(7). 36–41. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Gachard Breakdown of academic impact, for papers by Lourdes Florensa Breakdown of academic impact, for papers by Marie‐Christine Kyrtsonis Breakdown of academic impact, for papers by Odilia B. J. Corneth Breakdown of academic impact, for papers by María Luz Sánchez Breakdown of academic impact, for papers by Pascale De Paepe Breakdown of academic impact, for papers by S O'Brien Breakdown of academic impact, for papers by Manfred Hensel Breakdown of academic impact, for papers by Paula G. Heller Breakdown of academic impact, for papers by Kenichi Chiba
Rankless by CCL
2026